---
title: "Weekly Recap | DUALITYBIO-B -1.92%, consensus target above spot"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/305531916.md"
description: "DUALITYBIO-B fell 1.92% this week to close at HK$102.2, while the Hang Seng Index dropped 3.32%, leaving the stock about 1.4 percentage points ahead of the benchmark. The week started strong: the stock rose through Monday to Wednesday, touching HK$112.4 intraday on Wednesday, before a sharp pullback on Thursday dragged it down to HK$101.3 at the low. Weekly amplitude was 10.4%."
datetime: "2026-11-14T05:48:43.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/305531916.md)
  - [en](https://longbridge.com/en/news/305531916.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/305531916.md)
generator: "portal-rs"
---

# Weekly Recap | DUALITYBIO-B -1.92%, consensus target above spot

## The Week

DUALITYBIO-B (9606.HK) fell 1.92% this week to close at HK$102.2, while the Hang Seng Index dropped 3.32%, leaving the stock about 1.4 percentage points ahead of the benchmark. The week started strong: the stock rose through Monday to Wednesday, touching HK$112.4 intraday on Wednesday, before a sharp pullback on Thursday dragged it down to HK$101.3 at the low. Weekly amplitude was 10.4%. Average daily volume of roughly 518,000 shares sat about 41% below the 60-day median, reflecting a quiet tape. No major catalysts emerged during the week.

## Analyst Ratings

Of the 8 brokers covering the stock, 6 rate it buy and 2 rate it overweight, with no hold, underweight or sell ratings; the consensus rating is strong buy. The consensus target price is HK$395.78, roughly 287.3% above the latest close of HK$102.2. Target prices range from HK$276.06 to HK$502.29, showing wide dispersion. Among 52 biotechnology names, the stock ranks 12th by analyst ratings.

## The Week Ahead

Hong Kong releases unemployment data on Tuesday 17 November (prior 3.9%) and CPI on Friday 20 November (prior 1.9%). On the company side, DUALITYBIO-B reports fiscal Q3 2026 results after market close on Friday 27 November, making that the nearest fundamental checkpoint.

*This article is generated by LongbridgeAI from market data, for information only and not investment advice.*

### Related Stocks

- [09606.HK](https://longbridge.com/en/quote/09606.HK.md)

## Related News & Research

- [DUALITYBIO-B  Spends Over HKD17M on Buyback of 158,000 Shares on Wed](https://longbridge.com/en/news/303482424.md)
- [Duality Biotherapeutics Chairman Zhu Plans to Double Share Purchases to Up to USD 10 Million](https://longbridge.com/en/news/303394132.md)
- [Tesla Cybercab’s ‘Autonomy Subscription’ covers all bases for a self-driving car](https://longbridge.com/en/news/306297563.md)
- [Tesla expands Supercharger Waitlist to 300 sites across the U.S.](https://longbridge.com/en/news/306189672.md)
- [The Tesla Cybercab Is Now Available In Dallas](https://longbridge.com/en/news/306159915.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**